{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:08:27Z","timestamp":1793419707792,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973361"],"award-info":[{"award-number":["81973361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20202009"],"award-info":[{"award-number":["BK20202009"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242202"],"award-info":[{"award-number":["7242202"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.119038","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:57:25Z","timestamp":1769515045000},"page":"119038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["V-domain immunoglobulin suppressor of T-cell activation regulates CD4+ T cell activation and podocyte function through PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"195","author":[{"given":"Zhijie","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-0102","authenticated-orcid":false,"given":"Xinzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.biopha.2026.119038_bib1","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.biopha.2026.119038_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of human systemic lupus erythematosus: a cellular perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2026.119038_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BOR.0000000000000778","article-title":"Double-negative T cells in autoimmune diseases","volume":"33","author":"Li","year":"2021","journal-title":"Curr. Opin. Rheuma."},{"issue":"7","key":"10.1016\/j.biopha.2026.119038_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350603","article-title":"CD4(+)CD57(+) senescent T cells as promoters of systemic lupus erythematosus pathogenesis and the therapeutic potential of senolytic BCL-2 inhibitor","volume":"54","author":"Jiang","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.biopha.2026.119038_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/BOR.0000000000000777","article-title":"Cellular aspects of the pathogenesis of lupus nephritis","volume":"33","author":"Chang","year":"2021","journal-title":"Curr. Opin. Rheuma."},{"key":"10.1016\/j.biopha.2026.119038_bib7","article-title":"Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy","volume":"14","author":"Jiang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119038_bib8","doi-asserted-by":"crossref","first-page":"1324540","DOI":"10.3389\/fphar.2024.1324540","article-title":"Urinary biomarkers associated with podocyte injury in lupus nephritis","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119038_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106153","article-title":"A comprehensive insight into autophagy and its potential signaling pathways as a therapeutic target in podocyte injury","volume":"143","author":"Teh","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119038_bib10","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1159\/000373989","article-title":"Enhanced epithelial-to-mesenchymal transition associated with lysosome dysfunction in podocytes: role of p62\/Sequestosome 1 as a signaling hub","volume":"35","author":"Li","year":"2015","journal-title":"Cell Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2026.119038_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: a potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.biopha.2026.119038_bib12","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160086","article-title":"Spironolactone promotes autophagy via inhibiting PI3K\/AKT\/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress","volume":"36","author":"Li","year":"2016","journal-title":"Biosci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.119038_bib13","first-page":"848","article-title":"Platycodon grandiflorus polysaccharides combined with hesperidin exerted the synergistic effect of relieving ulcerative colitis in mice by modulating PI3K\/AKT and JAK2\/STAT3 signaling pathways","volume":"23","author":"Liu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2026.119038_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110479","article-title":"Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K\/AKT\/mTOR pathways to protect against diabetic nephropathy in mice","volume":"129","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-019-1091-2","article-title":"Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4","volume":"18","author":"Qin","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6475","key":"10.1016\/j.biopha.2026.119038_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay0524","article-title":"VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance","volume":"367","author":"ElTanbouly","year":"2020","journal-title":"Science"},{"issue":"522","key":"10.1016\/j.biopha.2026.119038_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax1159","article-title":"PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus","volume":"11","author":"Han","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.biopha.2026.119038_bib18","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s10565-023-09833-6","article-title":"Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-kappaB pathway","volume":"39","author":"Yang","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/acs.chemrestox.4c00449","article-title":"Activation of V-Domain Immunoglobulin Suppressor of T-Cell Activation by Baloxavir Marboxil Ameliorates Systemic Lupus Erythematosus through Inhibiting Lysophosphatidylcholine\/CD40 Ligand","volume":"38","author":"Luo","year":"2025","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119038_bib20","first-page":"195","article-title":"Progress in approved drugs from natural product resources","volume":"22","author":"Luo","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib21","first-page":"1","article-title":"Combination strategies for first-line treatment of patients with unresectable hepatocellular carcinoma: prospect of natural products","volume":"22","author":"Zhang","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119038_bib22","first-page":"387","article-title":"Hernandezine promotes cancer cell apoptosis and disrupts the lysosomal acidic environment and cathepsin D maturation","volume":"22","author":"Feng","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymthe.2022.09.013","article-title":"NAMPT is a metabolic checkpoint of IFNgamma-producing CD4(+) T cells in lupus nephritis","volume":"31","author":"Li","year":"2023","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119038_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111114","article-title":"Inducible deletion of Ezh2 in CD4(+) T cells inhibits kidney T cell infiltration and prevents interstitial nephritis in MRL\/lpr lupus-prone mice","volume":"27","author":"Zheng","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119038_bib26","doi-asserted-by":"crossref","first-page":"1217121","DOI":"10.3389\/fimmu.2023.1217121","article-title":"Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus","volume":"14","author":"Lyu","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119038_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114379","article-title":"The PP2A regulatory subunit PPP2R2A controls NAD(+) biosynthesis to regulate T cell subset differentiation in systemic autoimmunity","volume":"43","author":"Pan","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.119038_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108796","article-title":"BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway","volume":"114","author":"Hu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2026.119038_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/TP.0000000000004469","article-title":"CD40-CD40L blockade: update on novel investigational therapeutics for transplantation","volume":"107","author":"Singh","year":"2023","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.biopha.2026.119038_bib30","first-page":"480","article-title":"Andrographolide sulfonate alleviates rheumatoid arthritis by inhibiting glycolysis-mediated activation of PI3K\/AKT to restrain Th17 cell differentiation","volume":"23","author":"Jiang","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.biopha.2026.119038_bib31","article-title":"A novel long noncoding RNA lincRNA00892 activates CD4(+) T cells in systemic lupus erythematosus by regulating CD40L","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib32","first-page":"47","article-title":"Protective mechanisms of Leontopodium leontopodioides extracts on lipopolysaccharide-induced acute kidney injury viathe NF-kappaB\/NLRP3 pathway","volume":"21","author":"Bai","year":"2023","journal-title":"Chin. J. Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119038_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189351","article-title":"VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis","volume":"1880","author":"Niu","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2026.119038_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119966","article-title":"Intracellular and exosomal localization of the negative checkpoint regulator VISTA in immune cells","volume":"1872","author":"Dubbel","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.biopha.2026.119038_bib35","article-title":"Hyperglycemia drives lmmune evasion in colorectal cancer through VISTA stabilization","author":"Liu","year":"2026","journal-title":"Cell Commun. Signal."},{"issue":"7779","key":"10.1016\/j.biopha.2026.119038_bib36","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-019-1674-5","article-title":"VISTA is an acidic pH-selective ligand for PSGL-1","volume":"574","author":"Johnston","year":"2019","journal-title":"Nature"},{"issue":"95","key":"10.1016\/j.biopha.2026.119038_bib37","doi-asserted-by":"crossref","first-page":"eadi7418","DOI":"10.1126\/sciimmunol.adi7418","article-title":"LRIG1 engages ligand VISTA and impairs tumor-specific CD8(+) T cell responses","volume":"9","author":"Ta","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2026.119038_bib38","article-title":"Ligand-receptor interactions of V-domain Ig-containing suppressor of T cell activation and programmed death-1 suppress the anticancer activities of T cells","volume":"28","author":"Abooali","year":"2025","journal-title":"Immunooncol. Technol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imm.13001","article-title":"VSIG-3 as a ligand of VISTA inhibits human T-cell function","volume":"156","author":"Wang","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.biopha.2026.119038_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217581","article-title":"Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment","volume":"616","author":"Abooali","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-020-00917-y","article-title":"VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy","volume":"13","author":"Huang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119038_bib42","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cellsig.2012.06.009","article-title":"Activation of PI3K\/Akt signaling by n-terminal SH2 domain mutants of the p85alpha regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain","volume":"24","author":"Hofmann","year":"2012","journal-title":"Cell Signal."},{"issue":"29","key":"10.1016\/j.biopha.2026.119038_bib43","doi-asserted-by":"crossref","first-page":"27455","DOI":"10.1074\/jbc.M100556200","article-title":"Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase","volume":"276","author":"Cuevas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119038_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2024.08.004","article-title":"Unveiling the role of PIK3R1 in cancer: a comprehensive review of regulatory signaling and therapeutic implications","volume":"106-107","author":"Gupta","year":"2024","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.biopha.2026.119038_bib45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ecoenv.2018.06.055","article-title":"Mechanism and effects of Zearalenone on mouse T lymphocytes activation in vitro","volume":"162","author":"Cai","year":"2018","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"5","key":"10.1016\/j.biopha.2026.119038_bib46","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1067\/mai.2002.124259","article-title":"T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse","volume":"109","author":"Nel","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12964-022-00884-6","article-title":"Podocyte specific deletion of PKM2 ameliorates LPS-induced podocyte injury through beta-catenin","volume":"20","author":"Alquraishi","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib48","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1080\/21691401.2019.1601630","article-title":"Geniposide alleviates lipopolysaccharide-caused apoptosis of murine kidney podocytes by activating Ras\/Raf\/MEK\/ERK-mediated cell autophagy","volume":"47","author":"Li","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119038_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.biopha.2026.119038_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tins.2009.11.003","article-title":"mTOR signaling: at the crossroads of plasticity, memory and disease","volume":"33","author":"Hoeffer","year":"2010","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119038_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2026.119038_bib52","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2018-213028","article-title":"Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-alpha in lupus nephritis","volume":"77","author":"Qi","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.biopha.2026.119038_bib53","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fimmu.2020.01546","article-title":"T cells and acute kidney injury: a two-way relationship","volume":"11","author":"Dellepiane","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119038_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00296-010-1771-0","article-title":"Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis","volume":"32","author":"Xing","year":"2012","journal-title":"Rheuma. Int."},{"issue":"6","key":"10.1016\/j.biopha.2026.119038_bib55","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41401-021-00773-7","article-title":"Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells","volume":"43","author":"Du","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2026.119038_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1520570","article-title":"Immune imbalance in lupus nephritis: the intersection of T-Cell and ferroptosis","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119038_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112566","article-title":"Cordyceps protein alleviates renal injury by inhibiting T cell infiltration and Th1 cell differentiation in lupus nephritis mice","volume":"138","author":"Liao","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119038_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11030949","article-title":"Rapamycin treatment alleviates chronic GVHD-induced lupus nephritis in mice by recovering IL-2 production and regulatory T cells while inhibiting effector T cells activation","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119038_bib59","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1749-6632.1997.tb52088.x","article-title":"Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function","volume":"815","author":"Lipsky","year":"1997","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119038_bib60","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.intimp.2012.08.013","article-title":"Glycyrrhizin regulates CD4+T cell response during liver fibrogenesis via JNK, ERK and PI3K\/AKT pathway","volume":"14","author":"Tu","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119038_bib61","first-page":"346","article-title":"Ustusolate E and 11alpha-Hydroxy-Ustusolate E induce apoptosis in cancer cell lines by regulating the PI3K\/AKT\/mTOR and p-53 pathways","volume":"23","author":"Rehmutulla","year":"2025","journal-title":"Chin. J. Nat. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:04:00Z","timestamp":1773986640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":61,"alternative-id":["S0753332226000703"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119038","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"V-domain immunoglobulin suppressor of T-cell activation regulates CD4+ T cell activation and podocyte function through PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119038"}}